Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-mercapto-2-methylpropanoyl-l-cysteine
2. De-019
3. De019
4. L-cysteine, N-(2-mercapto-2-methyl-1-oxopropyl)-
5. N-(2-mercapto-2-methylpropionyl)-l-cysteine
6. Rimatil
7. Sa 96
8. Sa-96
9. Tiobutarit
1. 65002-17-7
2. Tiobutarit
3. Rimatil
4. N-(2-mercapto-2-methylpropionyl)-l-cysteine
5. Thiobutarit
6. Bucilant
7. De-019
8. (r)-3-mercapto-2-(2-mercapto-2-methylpropanamido)propanoic Acid
9. (2r)-2-[(2-methyl-2-sulfanylpropanoyl)amino]-3-sulfanylpropanoic Acid
10. N-(2-mercapto-2-methylpropanoyl)-l-cysteine
11. R80lra5wtf
12. Chembl80830
13. L-cysteine, N-(2-mercapto-2-methyl-1-oxopropyl)-
14. Dsstox_cid_28513
15. Dsstox_rid_82785
16. Dsstox_gsid_48587
17. Sa96
18. Bucilamina
19. Bucillaminum
20. (r)-3-mercapto-2-(2-mercapto-2-methylpropanamido)-propanoic Acid
21. Cas-65002-17-7
22. Bucilamina [spanish]
23. Bucillaminum [latin]
24. Bucillamine [inn:jan]
25. Unii-r80lra5wtf
26. N-(2-mercapto-2-methyl-1-oxopropyl)-l-cysteine
27. Ccris 5260
28. Sa-96
29. Ncgc00182062-02
30. Ncgc00183271-01
31. Bucilant (tn)
32. N-(2-mercaptoisobutyryl)-l-cysteine
33. Bucillamine [mi]
34. Bucillamine [inn]
35. Bucillamine [jan]
36. Bucillamine (jp17/inn)
37. Bucillamine [mart.]
38. Bucillamine [who-dd]
39. Mls006010100
40. Schembl121965
41. Dtxsid2048587
42. Chebi:31312
43. Zinc20222
44. Bcp12127
45. Tox21_112916
46. Tox21_113147
47. Bdbm50406934
48. Mfcd00867570
49. Rb3025
50. Akos015841445
51. Akos015895462
52. Am62722
53. Db12160
54. Ks-1449
55. Ac-32465
56. Smr004701240
57. Hy-118530
58. D01809
59. 002b177
60. A834941
61. Sr-01000883966
62. Q-101254
63. Q4982752
64. Sr-01000883966-1
65. (2r)-2-[(2-methyl-2-sulfanyl-propanoyl)amino]-3-sulfanyl-propanoic Acid
66. (2r)-3-mercapto-2-[(2-mercapto-2-methyl-1-oxopropyl)amino]propanoic Acid
Molecular Weight | 223.3 g/mol |
---|---|
Molecular Formula | C7H13NO3S2 |
XLogP3 | 0.4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 223.03368562 g/mol |
Monoisotopic Mass | 223.03368562 g/mol |
Topological Polar Surface Area | 68.4 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 218 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01C - Specific antirheumatic agents
M01CC - Penicillamine and similar agents
M01CC02 - Bucillamine
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?